125 related articles for article (PubMed ID: 18007347)
1. Highly lipophilic benzoxazoles with potential antibacterial activity.
Vinsová J; Horák V; Buchta V; Kaustová J
Molecules; 2005 Aug; 10(7):783-93. PubMed ID: 18007347
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di-tert-butylbenzoxazoles.
Vinsova J; Cermakova K; Tomeckova A; Ceckova M; Jampilek J; Cermak P; Kunes J; Dolezal M; Staud F
Bioorg Med Chem; 2006 Sep; 14(17):5850-65. PubMed ID: 16784871
[TBL] [Abstract][Full Text] [Related]
3. Novel benzoxazoles: synthesis and antibacterial, antifungal, and antitubercular activity against antibiotic-resistant and -sensitive microbes.
Arisoy M; Temiz-Arpaci O; Kaynak-Onurdag F; Ozgen S
Z Naturforsch C J Biosci; 2013; 68(11-12):453-60. PubMed ID: 24601083
[TBL] [Abstract][Full Text] [Related]
4. Lipase-catalyzed kinetic resolution of novel antitubercular benzoxazole derivatives.
Łukowska-Chojnacka E; Kowalkowska A; Napiórkowska A
Chirality; 2018 Apr; 30(4):457-468. PubMed ID: 29274237
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimicrobial activity of some 5-[2-(morpholin-4-yl)acetamido] and/or 5-[2-(4-substituted piperazin-1-yl)acetamido]-2-(p-substituted phenyl)benzoxazoles.
Temiz-Arpaci O; Ozdemir A; Yalçin I; Yildiz I; Aki-Sener E; Altanlar N
Arch Pharm (Weinheim); 2005 Mar; 338(2-3):105-11. PubMed ID: 15765492
[TBL] [Abstract][Full Text] [Related]
6. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Nov; 22(21):6134-45. PubMed ID: 25282650
[TBL] [Abstract][Full Text] [Related]
7. Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity.
Oliveira PFM; Guidetti B; Chamayou A; André-Barrès C; Madacki J; Korduláková J; Mori G; Orena BS; Chiarelli LR; Pasca MR; Lherbet C; Carayon C; Massou S; Baron M; Baltas M
Molecules; 2017 Sep; 22(9):. PubMed ID: 28862683
[TBL] [Abstract][Full Text] [Related]
8. Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides.
Pitta E; Rogacki MK; Balabon O; Huss S; Cunningham F; Lopez-Roman EM; Joossens J; Augustyns K; Ballell L; Bates RH; Van der Veken P
J Med Chem; 2016 Jul; 59(14):6709-28. PubMed ID: 27348630
[TBL] [Abstract][Full Text] [Related]
9. New series of isoniazid hydrazones linked with electron-withdrawing substituents.
Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J
Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878
[TBL] [Abstract][Full Text] [Related]
10. Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212.
Biava M; Cesare Porretta G; Deidda D; Pompei R; Tafi A; Manetti F
Bioorg Med Chem; 2003 Feb; 11(4):515-20. PubMed ID: 12538016
[TBL] [Abstract][Full Text] [Related]
11. MymA Bioactivated Thioalkylbenzoxazole Prodrug Family Active against
Moure AL; Narula G; Sorrentino F; Bojang A; Tsui CKM; Sao Emani C; Porras-De Francisco E; Díaz B; Rebollo-López MJ; Torres-Gómez PA; López-Román EM; Camino I; Casado Castro P; Guijarro López L; Ortega F; Ballell L; Barros-Aguirre D; Remuiñán Blanco M; Av-Gay Y
J Med Chem; 2020 May; 63(9):4732-4748. PubMed ID: 32275415
[TBL] [Abstract][Full Text] [Related]
12. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimycobacterial and photosynthesis-inhibiting evaluation of 2-[(E)-2-substituted-ethenyl]-1,3-benzoxazoles.
Imramovsky A; Kozic J; Pesko M; Stolarikova J; Vinsova J; Kralova K; Jampilek J
ScientificWorldJournal; 2014; 2014():705973. PubMed ID: 25197708
[TBL] [Abstract][Full Text] [Related]
14. Pyrrolnitrin and related pyrroles endowed with antibacterial activities against Mycobacterium tuberculosis.
Di Santo R; Costi R; Artico M; Massa S; Lampis G; Deidda D; Pompei R
Bioorg Med Chem Lett; 1998 Oct; 8(20):2931-6. PubMed ID: 9873650
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents.
Jardosh HH; Patel MP
Eur J Med Chem; 2013 Jul; 65():348-59. PubMed ID: 23747804
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new 4-isopropylthiazole hydrazide analogs and some derived clubbed triazole, oxadiazole ring systems--a novel class of potential antibacterial, antifungal and antitubercular agents.
Mallikarjuna BP; Sastry BS; Suresh Kumar GV; Rajendraprasad Y; Chandrashekar SM; Sathisha K
Eur J Med Chem; 2009 Nov; 44(11):4739-46. PubMed ID: 19589626
[TBL] [Abstract][Full Text] [Related]
17. [Antitubercular effect of capreomycin in vitro].
Janowiec M
Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
[No Abstract] [Full Text] [Related]
18. Experimental in vitro efficacy study on the interaction of epiroprim plus isoniazid against Mycobacterium tuberculosis.
Dosso M; Ouattara L; Cherif AM; Bouzid SA; Haller L; Fernex M
Chemotherapy; 2001; 47(2):123-7. PubMed ID: 11173814
[TBL] [Abstract][Full Text] [Related]
19. Heterocyclic benzazole derivatives with antimycobacterial in vitro activity.
Kocí J; Klimesová V; Waisser K; Kaustová J; Dahse HM; Möllmann U
Bioorg Med Chem Lett; 2002 Nov; 12(22):3275-8. PubMed ID: 12392731
[TBL] [Abstract][Full Text] [Related]
20. Antimycobacterial activity of 3,4-dichlorophenyl-ureas, N,N-diphenyl-ureas and related derivatives.
Scozzafava A; Mastrolorenzo A; Supuran CT
J Enzyme Inhib; 2001 Nov; 16(5):425-32. PubMed ID: 11916148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
